AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. NXTC
  4. [S-3] NextCure, Inc. Shelf Registration Statement

[S-3] NextCure, Inc. Shelf Registration Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-3
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock NXTC logo
Nextcure

NASDAQ:NXTC

NXTC Rankings

#8916 Ranked by Market Cap
N/A Ranked by Dividends

NXTC Latest News

Jul 24, 2025
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
Jun 16, 2025
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
May 29, 2025
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
May 1, 2025
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Apr 4, 2025
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

NXTC Latest SEC Filings

Jul 14, 2025
[8-K] NextCure, Inc. Reports Material Event
Jul 10, 2025
[8-K] NextCure, Inc. Reports Material Event
Jun 24, 2025
[Form 4] NextCure, Inc. Insider Trading Activity
Jun 24, 2025
[Form 4] NextCure, Inc. Insider Trading Activity
Jun 24, 2025
[Form 4] NextCure, Inc. Insider Trading Activity

NXTC Stock Data

12.16M
2.37M
7.01%
52.3%
0.24%
Biotechnology
Pharmaceutical Preparations
United States
BELTSVILLE